Assessment of Leishmanicidal and Trypanocidal Activities of Aliphatic Diamine Derivatives. (10th August 2013)
- Record Type:
- Journal Article
- Title:
- Assessment of Leishmanicidal and Trypanocidal Activities of Aliphatic Diamine Derivatives. (10th August 2013)
- Main Title:
- Assessment of Leishmanicidal and Trypanocidal Activities of Aliphatic Diamine Derivatives
- Authors:
- Yamanaka, Celina N.
Giordani, Raquel B.
Rezende, Celso O.
Eger, Iriane
Kessler, Rafael L.
Tonini, Maiko L.
de, Milene H.
Araújo, Debora P.
Zuanazzi, Jose A.
de, Mauro V.
Steindel, Mario - Abstract:
- <abstract abstract-type="main" id="cbdd12191-abs-0001"> <title> <x xml:space="preserve">Abstract</x> </title> <p>Leishmanicidal and trypanocidal activity of seventeen lipophilic diamines was evaluated <italic>in vitro</italic> against <italic>Leishmania braziliensis</italic>, <italic> L. chagasi</italic>, and <italic>Trypanosoma cruzi</italic>. Twelve compounds presented anti‐<italic>Leishmania</italic> and six showed anti‐<italic>T. cruzi</italic> amastigote activity. Compound <bold>14</bold> (<italic>N</italic>‐tetradecyl‐1, 4‐butanediamine) was the most active against both <italic>L. braziliensis</italic> (IC<sub>50</sub> = 2.6 μ<sc>m</sc>) and <italic>L. chagasi</italic> (IC<sub>50</sub> = 3.0 μ<sc>m</sc>) which showed a selectivity index (SI) &gt;100. <italic>N</italic>‐decyl‐1, 6‐hexanediamine (compound <bold>9</bold>) presented an IC<sub>50</sub> = 1.6 μ<sc>m</sc> and SI &gt;187 and was over six times more potent than the reference drug benznidazole against <italic>T. cruzi</italic>. Treatment of infected or uninfected macrophages with compounds <bold>9</bold> and <bold>14</bold> did not induce significant TNFα and NO production. Four compounds (<bold>15</bold>, <bold> 16</bold>, <bold> 22</bold>, and <bold>23</bold>) inhibited 78.9%, 77.7%, 83.7%, and 70.1% of rTRLb activity, respectively, and compound <bold>23</bold> inhibited 73.3% of rTRTc activity at 100 μ<sc>m</sc>. A concentration‐dependent effect on mitochondrial membrane depolarization was observed in<abstract abstract-type="main" id="cbdd12191-abs-0001"> <title> <x xml:space="preserve">Abstract</x> </title> <p>Leishmanicidal and trypanocidal activity of seventeen lipophilic diamines was evaluated <italic>in vitro</italic> against <italic>Leishmania braziliensis</italic>, <italic> L. chagasi</italic>, and <italic>Trypanosoma cruzi</italic>. Twelve compounds presented anti‐<italic>Leishmania</italic> and six showed anti‐<italic>T. cruzi</italic> amastigote activity. Compound <bold>14</bold> (<italic>N</italic>‐tetradecyl‐1, 4‐butanediamine) was the most active against both <italic>L. braziliensis</italic> (IC<sub>50</sub> = 2.6 μ<sc>m</sc>) and <italic>L. chagasi</italic> (IC<sub>50</sub> = 3.0 μ<sc>m</sc>) which showed a selectivity index (SI) &gt;100. <italic>N</italic>‐decyl‐1, 6‐hexanediamine (compound <bold>9</bold>) presented an IC<sub>50</sub> = 1.6 μ<sc>m</sc> and SI &gt;187 and was over six times more potent than the reference drug benznidazole against <italic>T. cruzi</italic>. Treatment of infected or uninfected macrophages with compounds <bold>9</bold> and <bold>14</bold> did not induce significant TNFα and NO production. Four compounds (<bold>15</bold>, <bold> 16</bold>, <bold> 22</bold>, and <bold>23</bold>) inhibited 78.9%, 77.7%, 83.7%, and 70.1% of rTRLb activity, respectively, and compound <bold>23</bold> inhibited 73.3% of rTRTc activity at 100 μ<sc>m</sc>. A concentration‐dependent effect on mitochondrial membrane depolarization was observed in <italic>T. cruzi</italic> epimastigotes treated with compound <bold>9</bold>, suggesting this mechanism may be involved in the trypanocidal effect. On the contrary, in <italic>L. braziliensis</italic> promastigotes treated with compound <bold>14</bold>, no mitochondrial depolarization was observed. Our results demonstrate that <italic>N</italic>‐decyl‐1, 6‐hexanediamine and <italic>N</italic>‐tetradecyl‐1, 4‐butanediamine are promising molecules for the development of novel leading compounds against <italic>T. cruzi</italic> and <italic>Leishmania</italic> spp., particularly given a possible alternative mechanism of action.</p> </abstract> … (more)
- Is Part Of:
- Chemical biology & drug design. Volume 82:Number 6(2013:Dec.)
- Journal:
- Chemical biology & drug design
- Issue:
- Volume 82:Number 6(2013:Dec.)
- Issue Display:
- Volume 82, Issue 6 (2013)
- Year:
- 2013
- Volume:
- 82
- Issue:
- 6
- Issue Sort Value:
- 2013-0082-0006-0000
- Page Start:
- 697
- Page End:
- 704
- Publication Date:
- 2013-08-10
- Subjects:
- Drugs -- Design -- Periodicals
Pharmaceutical chemistry -- Periodicals
Biochemistry -- Periodicals
615.19005 - Journal URLs:
- http://gateway.ovid.com/ovidweb.cgi?T=JS&MODE=ovid&NEWS=n&PAGE=toc&D=ovft&AN=01253034-000000000-00000 ↗
http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1747-0285 ↗
http://www.blackwell-synergy.com/loi/jpp ↗
http://onlinelibrary.wiley.com/ ↗ - DOI:
- 10.1111/cbdd.12191 ↗
- Languages:
- English
- ISSNs:
- 1747-0277
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 3139.120000
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 3191.xml